Digestive Disease Interventions 2022; 06(02): 113-120
DOI: 10.1055/s-0042-1745858
Review Article

Diagnosis and Management of Acute and Chronic Portomesenteric Venous Thrombosis

1   Department of Radiology, Section of Interventional Radiology, LSU New Orleans, New Orleans, Louisiana
› Author Affiliations

Abstract

Thrombosis of the portal and mesenteric veins is relatively uncommon. Thrombosis can be acute or chronic. Management is dictated by symptoms on clinical presentation. Acute symptomatic mesenteric vein thrombosis may require aggressive endovascular intervention with mechanical thrombectomy, thromboaspiration, infusion of thrombolytic drugs, TIPS creation or surgery. Chronic, symptomatic portal and mesenteric vein thrombosis usually requires recanalization of occluded segments and stent placement. The three main catheterization techniques for access into the portal venous system are: transhepatic, transjugular and trans-splenic. Evidence-based therapeutic strategies for acute and chronic portal and mesenteric vein thrombosis have not been established. There are no prospective comparative studies to support superiority of any given technique in the management of these conditions. The purpose of this review is to present an overview of the etiology, physiopathology, clinical presentation, and management of acute and chronic portal and mesenteric vein thrombosis.



Publication History

Received: 25 October 2021

Accepted: 24 January 2022

Article published online:
25 April 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Blumberg SN, Maldonado TS. Mesenteric venous thrombosis. J Vasc Surg Venous Lymphat Disord 2016; 4 (04) 501-507
  • 2 Ponziani F, Zocco M, Campanele C. et al. Portal vein thrombosis: Insight into physiopathology, diagnosis and treatment. In: Gastroenterol WJ. ed; 2010
  • 3 Ju C, Li X, Gadani S, Kapoor B, Partovi S. Portal Vein Thrombosis: Diagnosis and Endovascular Management. RoFo Fortschr Geb Rontgenstr Nuklearmed 2021; 10: 14
  • 4 Kato A, Shimizu H, Ohtsuka M, Yoshitomi H, Furukawa K, Miyazaki M. Portal vein stent placement for the treatment of postoperative portal vein stenosis: long-term success and factor associated with stent failure. BMC Surg 2017; 17 (01) 11
  • 5 Liu FY, Wang MQ, Fan QS, Duan F, Wang ZJ, Song P. Interventional treatment for symptomatic acute-subacute portal and superior mesenteric vein thrombosis. World J Gastroenterol 2009; 15 (40) 5028-5034
  • 6 Lopera JE, Correa G, Brazzini A. et al. Percutaneous transhepatic treatment of symptomatic mesenteric venous thrombosis. J Vasc Surg 2002; 36 (05) 1058-1061
  • 7 Miyazaki M, Shimizu H, Ohtuka M. et al. Portal vein thrombosis after reconstruction in 270 consecutive patients with portal vein resections in hepatopancreatobiliary (HPB) surgery. Am J Surg 2017; 214 (01) 74-79
  • 8 Jeon UB, Kim CW, Kim TU. et al. Therapeutic efficacy and stent patency of transhepatic portal vein stenting after surgery. World J Gastroenterol 2016; 22 (44) 9822-9828
  • 9 Stein M, Link DP. Symptomatic spleno-mesenteric-portal venous thrombosis: recanalization and reconstruction with endovascular stents. J Vasc Interv Radiol 1999; 10 (03) 363-371
  • 10 Wei BJ, Zhai RY, Wang JF, Dai DK, Yu P. Percutaneous portal venoplasty and stenting for anastomotic stenosis after liver transplantation. World J Gastroenterol 2009; 15 (15) 1880-1885
  • 11 Wichman HJ, Cwikiel W, Keussen I. Interventional treatment of mesenteric venous occlusion. Pol J Radiol 2014; 79: 233-238
  • 12 Salembier A, Verhamme M, Verhamme P, Van Moerkercke W. Acute non-cirrhotic portal vein thrombosis : review. review Acta Gastroenterol Belg 2018; 81 (02) 318-322
  • 13 Lang SA, Loss M, Wohlgemuth WA, Schlitt HJ. Clinical management of Acute Portal/Mesenteric Vein Thrombosis. In: Viszeralmedizin, ed; 2014. 30. 394-400
  • 14 Alden D, Dudiy Y, Nassiri N, Friedland RJ, Amatulle P, Rosen RJ. Direct percutaneous transhepatic portomesenteric venous stenting in management of locally advanced pancreatic cancer. Am J Clin Oncol 2015; 38 (02) 127-129
  • 15 van Dijk LJ, van Petersen AS, Moelker A. Vascular imaging of the mesenteric vasculature. Best Pract Res Clin Gastroenterol 2017; 31 (01) 3-14
  • 16 Seedial SM, Mouli SK, Desai KR. Acute Portal Vein Thrombosis: Current Trends in Medical and Endovascular Management. Semin Intervent Radiol 2018; 35 (03) 198-202
  • 17 Qi X, Han G, Bai M, Fan D. Stage of portal vein thrombosis. J Hepatol 2011; 54 (05) 1080-1082 , author reply 1082–1083
  • 18 Maldonado TS, Blumberg SN, Sheth SU. et al. Mesenteric vein thrombosis can be safely treated with anticoagulation but is associated with significant sequelae of portal hypertension. J Vasc Surg Venous Lymphat Disord 2016; 4 (04) 400-406
  • 19 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol 2016; 64 (01) 179-202
  • 20 Allan BJ, Novak SM, Hogg ME, Zeh HJ. Robotic vascular resections during Whipple procedure. J Vis Surg 2018; 4: 13
  • 21 Cao G, Ko GY, Sung KB, Yoon HK, Gwon DI, Kim JH. Treatment of postoperative main portal vein and superior mesenteric vein thrombosis with balloon angioplasty and/or stent placement. Acta Radiol 2013; 54 (05) 526-532
  • 22 Pargewar SS, Desai SN, Rajesh S, Singh VP, Arora A, Mukund A. Imaging and radiological interventions in extra-hepatic portal vein obstruction. World J Radiol 2016; 8 (06) 556-570
  • 23 Thompson SM, Fleming CJ, Yohanathan L, Truty MJ, Kendrick ML, Andrews JC. Portomesenteric Venous Complications after Pancreatic Surgery with Venous Reconstruction: Imaging and Intervention. Radiographics 2020; 40 (02) 531-544
  • 24 Harding DJ, Perera MT, Chen F, Olliff S, Tripathi D. Portal vein thrombosis in cirrhosis: Controversies and latest developments. World J Gastroenterol 2015; 21 (22) 6769-6784
  • 25 Yang S, Fan X, Ding W. et al. Multidisciplinary stepwise management strategy for acute superior mesenteric venous thrombosis: an intestinal stroke center experience. Thromb Res 2015; 135 (01) 36-45
  • 26 Hanafy AS, Abd-Eisalam S, Dawoud MM. Randomized controlled trial of rivaroxaban versus warfarin in the management of acute, non-neoplastic portal vein thrombosis. In: Pharmacol V. ed; 2019. 113. 86-91
  • 27 Senzolo M, M Sartori T, Rossetto V. et al. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int 2012; 32 (06) 919-927
  • 28 Kelay A, Morgan-Rowe L, Constantinou J, Malago M, Ivancev K. Retrograde Stenting Under Transmesenteric Angiographic Guidance of an Occluded Superior Mesenteric Vein to Treat Life-Threatening Hemorrhage. Ann Vasc Surg 2016; 31: 209.e11-209.e15
  • 29 Entezari P, Riaz A, Thornburg B, Salem R. Percutaneous Ultrasound-Guided Superior and Inferior Mesenteric Vein Access for Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt: A Case Series. Cardiovasc Intervent Radiol 2021; 44 (03) 496-499
  • 30 Venkatesan AM, Kundu S, Sacks D. et al; Society of Interventional Radiology Standards of Practice Committee. Practice guidelines for adult antibiotic prophylaxis during vascular and interventional radiology procedures. [corrected] J Vasc Interv Radiol 2010; 21 (11) 1611-1630 , quiz 1631
  • 31 Ginsburg M, Ferral H, Alonzo MJ, Talamonti MS. Percutaneous transhepatic placement of a stent-graft to treat a delayed mesoportal hemorrhage after pancreaticoduodenectomy. World J Surg Oncol 2014; 12: 315
  • 32 Funaki B, Rosenblum J, Leef J. et al. Portal vein stenosis in children with segmental liver transplants: treatment with percutaneous transhepatic venoplasty. In: roentgenol AJ. ed; 1995
  • 33 Wolter K, Decker G, Kuetting D. et al. Interventional Treatment of Acute Portal Vein Thrombosis. RoFo Fortschr Geb Rontgenstr Nuklearmed 2018; 190 (08) 740-746
  • 34 Zemel G, Katzen BT, Becker GJ, Benenati JF, Sallee DS. Percutaneous transjugular portosystemic shunt. JAMA 1991; 266 (03) 390-393
  • 35 Thornburg B, Desai K, Hickey R. et al. Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Technical Considerations. Tech Vasc Interv Radiol 2016; 19 (01) 52-60
  • 36 Hall TC, Garcea G, Metcalfe M, Bilku D, Dennison AR. Management of acute non-cirrhotic and non-malignant portal vein thrombosis: a systematic review. World J Surg 2011; 35 (11) 2510-2520
  • 37 Qi X, Han G. Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature. Hepatol Int 2012; 6 (03) 576-590
  • 38 von Köckritz L, De Gottardi A, Trebicka J, Praktiknjo M. Portal vein thrombosis in patients with cirrhosis. Gastroenterol Rep (Oxf) 2017; 5 (02) 148-156
  • 39 Mugu VK, Thompson SM, Fleming CJ. et al. Evaluation of Technical Success, Efficacy, and Safety of Portomesenteric Venous Intervention following Nontransplant Hepatobiliary or Pancreatic Surgery. J Vasc Interv Radiol 2020; 31 (03) 416-424.e2
  • 40 Park JH, Yeo JH, Kim YS. et al. Portal vein stent for symptomatic malignant portal vein stenosis: A single-center experience. Curr Probl Cancer 2020; 44 (02) 100476
  • 41 Ferral H, Alonzo MJ, Datri J, Hogg M, Marsh R, Talamonti MS. Endovascular management of portal vein obstruction in hepatobiliary cancer patients. J Surg Oncol 2021; 10: 1002
  • 42 Kuban JD, Mahvash A, Sheth RA. Portomesenteric Intervention in the Cancer Patient. Endovasc Today 2020; 19: 56-63
  • 43 Marot A, Barbosa J, Duran R, Deltenre P, Denys A. Percutaneous Portal Vein Recanalization using self-expandable nitinol stents in patients with non-cirrhotic non-tumoral portal vein occlusion. In: Imaging DaI, ed; 2019
  • 44 Khan A, Kleive D, Aandahl EM. et al. Portal vein stent placement after hepatobiliary and pancreatic surgery. Langenbecks Arch Surg 2020; 405 (05) 657-664
  • 45 Ahmed O, Salaskar AL, Zangan S, Pillai A, Baker T. Transsplenic portal vein recanalization and direct intrahepatic portosystemic shunt placement to optimize liver transplantation. CVIR Endovasc 2020; 3 (01) 5
  • 46 Chu HH, Kim HC, Jae HJ. et al. Percutaneous transsplenic access to the portal vein for management of vascular complication in patients with chronic liver disease. Cardiovasc Intervent Radiol 2012; 35 (06) 1388-1395
  • 47 Zhang Y, Xu B-Y, Wang XB. et al. Prevalence and Clinical Significance of Portal Vein Thrombosis in Patients With Cirrhosis and Acute Decompensation. Clin Gastroenterol Hepatol 2020; 18 (11) 2564-2572.e1
  • 48 Radosevich PM, Ring EJ, LaBerge JM. et al. Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion. Radiology 1993; 186 (02) 523-527
  • 49 Ferral H, Gomez-Reyes E, Fimmel CJ. Post-Transjugular Intrahepatic Portosystemic Shunt Follow-Up and Management in the VIATORR Era. Tech Vasc Interv Radiol 2016; 19 (01) 82-88
  • 50 Wu M, Schuster M, Tadros M. Update on Management of Portal Vein Thrombosis and the Role of Novel Anticoagulants. J Clin Transl Hepatol 2019; 7 (02) 154-164